Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $57.3000 (0.07%) ($57.3000 - $57.3000) on Thu. Dec. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.23% (three month average) | RSI | 78 | Latest Price | $57.3000(0.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.1% a day on average for past five trading days. | Weekly Trend | HALO advances 2.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(33%) IWO(33%) IWM(31%) IWN(29%) | Factors Impacting HALO price | HALO will decline at least -1.115% in a week (0% probabilities). VIXM(-11%) XBI(-7%) VXX(-6%) IGOV(-5%) GLD(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.115% (StdDev 2.23%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $56.55(1.33%) | 10 Day Moving Average | $55.08(4.03%) | 20 Day Moving Average | $52.87(8.38%) | To recent high | 0% | To recent low | 48.8% | Market Cap | $7.831b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |